FI852359L - Dihydropyridinderivat. - Google Patents

Dihydropyridinderivat.

Info

Publication number
FI852359L
FI852359L FI852359A FI852359A FI852359L FI 852359 L FI852359 L FI 852359L FI 852359 A FI852359 A FI 852359A FI 852359 A FI852359 A FI 852359A FI 852359 L FI852359 L FI 852359L
Authority
FI
Finland
Prior art keywords
dihydropyridinderivat
Prior art date
Application number
FI852359A
Other languages
English (en)
Other versions
FI852359A0 (fi
Inventor
Roland Jaunin
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI852359A0 publication Critical patent/FI852359A0/fi
Publication of FI852359L publication Critical patent/FI852359L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI852359A 1984-06-27 1985-06-13 Dihydropyridinderivat. FI852359L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH309784 1984-06-27

Publications (2)

Publication Number Publication Date
FI852359A0 FI852359A0 (fi) 1985-06-13
FI852359L true FI852359L (fi) 1985-12-28

Family

ID=4248551

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852359A FI852359L (fi) 1984-06-27 1985-06-13 Dihydropyridinderivat.

Country Status (16)

Country Link
US (1) US4742069A (fi)
EP (1) EP0166422A1 (fi)
JP (1) JPS6118762A (fi)
CN (1) CN85105335A (fi)
AU (1) AU4399185A (fi)
DK (1) DK288085A (fi)
ES (2) ES8609253A1 (fi)
FI (1) FI852359L (fi)
GR (1) GR851554B (fi)
HU (1) HU193784B (fi)
IL (1) IL75595A0 (fi)
MC (1) MC1675A1 (fi)
NO (1) NO852576L (fi)
PH (1) PH21510A (fi)
PT (1) PT80719B (fi)
ZA (1) ZA854665B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
CN106011652B (zh) 2016-06-28 2017-12-26 宝山钢铁股份有限公司 一种磷化性能优异的冷轧低密度钢板及其制造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE3116129A1 (de) * 1981-04-23 1982-11-11 Hoechst Ag, 6000 Frankfurt 2-ketosulfonamide und verfahren zu ihrer herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
IL75595A0 (en) 1985-10-31
PT80719A (en) 1985-07-01
DK288085D0 (da) 1985-06-25
ZA854665B (en) 1986-02-26
FI852359A0 (fi) 1985-06-13
HU193784B (en) 1987-11-30
HUT37923A (en) 1986-03-28
NO852576L (no) 1985-12-30
ES8609253A1 (es) 1986-09-01
AU4399185A (en) 1986-01-02
PT80719B (en) 1987-04-23
ES8705388A1 (es) 1987-05-01
MC1675A1 (fr) 1986-06-03
US4742069A (en) 1988-05-03
DK288085A (da) 1985-12-28
PH21510A (en) 1987-11-10
CN85105335A (zh) 1987-01-14
GR851554B (fi) 1985-11-25
JPS6118762A (ja) 1986-01-27
ES551817A0 (es) 1987-05-01
ES544558A0 (es) 1986-09-01
EP0166422A1 (de) 1986-01-02

Similar Documents

Publication Publication Date Title
DE3583455D1 (de) Salbenbase.
DE3581430D1 (de) Detergens.
DE3585265D1 (de) Fibronektinpraeparate.
DE3581707D1 (de) Neigungsmesser.
DE3583080D1 (de) Mikrorechner.
FI77959B (fi) Hushaolls- eller motsvarande koeksanordning.
FI840024A (fi) Instaellbart saengbotten.
FI862531A (fi) Tumoernekrosisfaktor.
FI852540L (fi) Drivsystem foer vaexelstroemsmotorer.
FI843125A0 (fi) Tillaeggsmunstycke foer dammsugare.
DE3578421D1 (de) Glycidyloxydiketone.
DE3582060D1 (de) Homopropargylamine.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
DE3584628D1 (de) Xenocoumacine.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI80907B (fi) Kraftunderstoedd hudappliseringsapparat.
DE3579862D1 (de) Mikrorechner.
FI852864A0 (fi) Extraktionsprocess foer en loesning.
DE3587711D1 (de) Minaktivin.
DE3574867D1 (de) Aminokarnitine.
FI840086A (fi) Spolstyrningsapparat foer vakuumklosett.
FI83368B (fi) Handelvapen.
FI852359L (fi) Dihydropyridinderivat.
DE3585189D1 (de) Alpha-d-mannosidase hemmungsmittel.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO